In Brief: Nitric oxide
Executive Summary
Nitric oxide: The committee will conduct a general discussion of nitric oxide April 9 that is expected to address NO use and available data, particularly in primary pulmonary hypertension of neonates and acute respiratory distress syndrome, and potentially some preclinical data. The committee will meet at 8:30 a.m. both days at NIH's Masur Auditorium...